about
Poxvirus pathogenesisPLAUR polymorphisms and lung function in UK smokers.t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension.PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by group C streptococci grown in plasma.Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liverPAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypassProtease nexin-1 expression is altered in human breast cancer.Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosisPaediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complicationsAngiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice.Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoterAngiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.Acute alcohol-induced liver injury.Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assaysOxidative stress, plasminogen activator inhibitor 1, and lung fibrosisNew role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1Mechanisms and cell signaling in alcoholic liver disease.Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.Disappearance and formation rates of microaneurysms in early diabetic retinopathy.Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves.Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian WomanMetastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradationRemarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex.Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells.Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice.Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells.Plasminogen-binding proteins as an evasion mechanism of the host's innate immunity in infectious diseases
P2860
Q24634729-B99F8763-B68E-4D34-8077-62F8BD35F588Q33514135-F1BD6A3F-CA62-41D4-B184-314318E77F3CQ33735850-E39A9FBF-8E85-4C89-B97C-E5D97B1BF057Q33840622-BF5A8C43-6924-41AF-A63E-17E052650C00Q34002766-1BAB3722-DF19-46A3-B66F-96044B4F522BQ34405039-04AA4982-076D-4691-87C6-197CA0CE50BEQ34461462-43F02F5C-CD9C-4F4F-B0B8-4C14320F31C7Q34768102-E0E52EB2-BF09-4DE4-B624-AADFCBF475FBQ34779140-9EBEFB25-6605-41D9-BA6E-E55F4F0D9ABBQ34984527-76899CD9-DD2B-4116-A644-C361EF9947AAQ34992341-8B19719D-D594-4051-A38E-4FC87C2A51CEQ35200663-3C673784-7715-4092-B355-2D839684AF5CQ35554163-B7CEFC8E-47D4-428A-B2A6-CADA29634C1BQ35597576-79625046-C9D0-45C0-AA75-BCA701B23899Q35772792-9C616D73-F180-42ED-A4DE-1B0F78F8FC2AQ35960164-5570AD82-E42E-4692-BC60-FDF1833898EEQ36025557-C624C839-B65E-49DB-BDD2-3A9400897413Q36072526-9667AD76-0D24-471C-9799-63B0AE221C46Q36223980-C2F39B54-67A1-406E-8E92-B81CC684EE40Q36237406-999E5475-CAA8-4571-9759-567FB1C92245Q36269761-E617BDDE-E9B6-42E6-AE57-3DE9CD289A06Q36940906-24D7ED3A-C640-4536-B499-1E39A609FE17Q37108878-3DB2063B-B26A-4294-9619-80026832B466Q37111703-199BC489-5F65-4566-BFB4-FE08D3567061Q37127404-99C08708-734C-40F4-AD52-F6DA21C24B06Q37305691-FC410012-54E9-456B-BEC2-D563A5DA7C24Q37318169-4D622FD2-3444-4F6A-8149-45F98329814AQ37627304-215F199D-4785-43CB-AA4C-952AAEB89C29Q39561337-13AC7B76-D9F7-4ED5-A103-3A1C7B43225EQ41821585-8344820E-39C7-4E9C-8363-CC00A5E06A95Q41832676-06AEF57D-0C06-4482-8911-6A9BF024B9E0Q42836856-30B08078-73C1-4968-8176-824D4AD6EF43Q43192139-3864918F-FC45-4904-83CB-EC61E4D56004Q47098588-02DFE008-41FE-4889-A354-69A805744330Q47738050-C1415514-DE52-4A72-B513-D7748434CDD0Q51779283-BD718D5E-AD17-44AA-B802-2479CADF24FAQ54969476-87C7F4D1-BEFA-4796-85B3-21F0FDF17794Q57044366-F2936BFC-C0B9-487F-B23F-A8436E9BDE13
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Plasminogen activator inhibitors--a review.
@en
Plasminogen activator inhibitors--a review.
@nl
type
label
Plasminogen activator inhibitors--a review.
@en
Plasminogen activator inhibitors--a review.
@nl
prefLabel
Plasminogen activator inhibitors--a review.
@en
Plasminogen activator inhibitors--a review.
@nl
P1433
P1476
Plasminogen activator inhibitors--a review.
@en
P2093
Kruithof EK
P304
P577
1988-01-01T00:00:00Z